@inproceedings{inproceedings, title  = {{Extended multi-centre review of adjuvant pembrolizumab for renal cell carcinoma.}},

 publisher = {{American Society of Clinical Oncology (ASCO)}},

 url = {{https://doi.org/10.1200/jco.2026.44.7_suppl.458 }},

 year = {{2026}},

 month = {{3}},

 author = {{McCarthy E and Brown J and Wright D and Lindsay D and Waddell T and Pillai M and Agarwal A and Matthews D and Frazer RD and Pickering LM and Grumett SA et al}},

 doi = {{10.1200/jco.2026.44.7_suppl.458}},

 volume = {{44}},

 journal = {{Journal of Clinical Oncology}},

 issue = {{7_suppl}},

 pages = {{458-458}},

 note = {{Accessed on 2026/04/26}}}